manufacturing - International Biopharmaceutical Industry

Volume 5 Issue 3

Automated Sterile Manufacturing and Packaging Solutions Aiding Speed to Patient

The biologic market has grown expediently over the past few years, driven not only by the pandemic but also by the increasing demand for innovative therapies, the con...

12 October 2022 Volume 5 Issue 3 automated | biologic

Continue Reading →

news

Recipharm offers services to enable switch to next generation pMDI propellants

Global contract development and manufacturing organisation (CDMO) Recipharm, today announces that it is expanding its pMDI product development expertise to accommod...

29 April 2022 news GWP | manufacturing

Continue Reading →

news

Novartis turns cell therapy skill into contract manufacturing deal

Dive Brief: Novartis will manufacture an experimental cancer cell therapy for the small Philadelphia-based Carisma Therapeutics in a deal that marks another early ...

14 March 2022 news cell | contract

Continue Reading →

Volume 4 Issue 4

How Involved Should Biopharma CEOs Be In Outsourcing Activities?

When outsourcing drug development and manufacturing, how involved should the CEOs of emerging biopharma be in the requisite day-to-day activities and processes? Louis...

9 December 2021 Volume 4 Issue 4 Aristea Therapeutics | biopharma

Continue Reading →

Volume 4 Issue 4

Contamination Control Strategy

Regulatory bodies expect that pharmaceutical companies have a Contamination Control Strategy (CCS) in place that outlines the control of contamination of utilities, m...

9 December 2021 Volume 4 Issue 4 CCS | Contamination Control Strategy

Continue Reading →

news

J&J foresees end to not-for-profit sales of coronavirus vaccine

J&J has recorded far fewer sales of its coronavirus vaccine than competitors Pfizer and Moderna, partly due to its not-for-profit pricing but also to a series of ...

22 October 2021 news coronavirus vaccine | J&J

Continue Reading →

news

CureVac scales back mRNA manufacturing for coronavirus vaccine

While not acknowledged directly, the "corresponding changes in demand" could also stem from disappointing clinical trial results CureVac released for its vaccine in m...

17 September 2021 news coronavirus vaccine | CureVac

Continue Reading →

Volume 4 Issue 3

Shoring up Diagnostics Manufacturing for the Next Pandemic

As the global response to COVID-19 continues to move from a state of national lockdowns to the re-opening of societies, diagnostic assay developers are confronting tw...

1 September 2021 Volume 4 Issue 3 COVID-19 | Disease

Continue Reading →

Volume 4 Issue 3

Residual Impurities in Biopharmaceutical Products

Process-related impurities or residual impurities are formed at any time during upstream or downstream processes. They are compounds that are present at very low conc...

31 August 2021 Volume 4 Issue 3 biomanufactured | manufacturing

Continue Reading →

news

Wockhardt starts manufacturing and R&D facility in Dubai

With an aim to grow and further establish their international presence in pharmaceutical manufacturing, Wockhardt inaugurated a‘state-of-the-art’ manufacturing facili...

31 July 2018 news Dubai | facility

Continue Reading →